Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials.

Cancers (Basel) · 2021 · PMC8533780 · PMID 34680350

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

At 74 months median follow-up, the overall survival (OS) did not reach statistical significance (6-year OS 95% versus 94% with 125 versus 147 deaths for pertuzumab and placebo, respectively).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.